A great deal of recent research has identified chemoattractants and cellular activators responsible for neutrophil trafficking into inflamed tissues, as well as for lymphocyte homing to secondary lymphoid organs in the steady state and into foci of chronic inflammation ([1][1]–[5][2]).
No takes yet. Share an insight, caveat, or question.
William A. Müller (2001) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: